2-Chloro-5-Iodobenzoic Acid CAS 19094-56-5 Empagliflozin Agbedemeji Agbeyewo ≥99.0% (HPLC)

Apejuwe kukuru:

Orukọ Kemikali: 2-Chloro-5-Iodobenzoic Acid

CAS: 19094-56-5

Ayẹwo: ≥99.0% (HPLC)

Irisi: Funfun tabi Bia Awọn kirisita Yellow Yellow

Aarin ti Empagliflozin (CAS: 864070-44-0) fun itọju iru àtọgbẹ 2.

Didara to gaju, iṣelọpọ Iṣowo

Inquiry: alvin@ruifuchem.com


Alaye ọja

Jẹmọ Products

ọja Tags

Apejuwe:

Ipese Olupese, Iwa-mimọ giga, Iṣelọpọ Iṣowo
Orukọ Kemikali: 2-Chloro-5-Iodobenzoic Acid
CAS: 19094-56-5

Kemikali Properties:

Orukọ Kemikali 2-Chloro-5-Iodobenzoic Acid
Nọmba CAS Ọdun 19094-56-5
NỌMBA CAT RF-PI438
Iṣura Ipo Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn Toonu
Fọọmu Molecular C7H4ClIO2
Òṣuwọn Molikula 282.46
Solubility Tiotuka ni kẹmika
Brand Ruifu Kemikali

Awọn pato:

Nkan Awọn pato
Ifarahan Funfun tabi Bia Kirisita Yellow
Aseyori / Analysis Ọna ≥99.0% (HPLC)
Ojuami Iyo 161.0 ~ 163.0 ℃
Pipadanu lori Gbigbe ≤0.50%
Aloku lori Iginisonu ≤0.20%
Lapapọ Awọn Aimọ ≤1.0%
Awọn Irin Eru ≤20ppm
Aloku ti o ku Ethanol
Igbeyewo Standard Standard Enterprise
Lilo Agbedemeji ti Empagliflozin (CAS: 864070-44-0)

2-Chloro-5-Iodobenzoic Acid (CAS 19094-56-5) Ipa ọna Sintetiki

kas ọna 19094-56-5

Package & Ibi ipamọ:

Package: Igo, apo apamọwọ Aluminiomu, 25kg / Paali Drum, tabi gẹgẹbi ibeere alabara.

Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina ati ọrinrin.

Awọn anfani:

1

FAQ:

Ohun elo:

2-Chloro-5-Iodobenzoic Acid (CAS: 19094-56-5) le ṣee lo bi agbedemeji elegbogi ni iṣelọpọ ti Empagliflozin (CAS: 864070-44-0).Empagliflozin (orukọ iṣowo Jardiance) jẹ inhibitor ti iṣuu soda glucose co-transporter-2 (SGLT-2), ati pe o fa suga ninu ẹjẹ lati yọkuro nipasẹ awọn kidinrin ati yọkuro ninu ito.Ni Oṣu Kẹjọ Ọjọ 1, Ọdun 2014, Ile-iṣẹ Ounje ati Oògùn (FDA) fọwọsi oogun naa ni ifowosi fun itọju iru àtọgbẹ 2, lati ni ilọsiwaju ati iṣakoso glukosi ẹjẹ ti awọn agbalagba.Empagliflozin jẹ SGLT-2 kẹta ti o ṣe idiwọ awọn oogun ti a fọwọsi nipasẹ FDA.Awọn oogun inhibitor SGLT-2 meji miiran, Canagliflozin ati Dapagliflozin, ti o jẹ ti Johnson Pharmaceuticals, AstraZeneca ati Bristol-Myers Squibb lẹsẹsẹ, ti fọwọsi nipasẹ FDA ni Oṣu kọkanla ọdun 2013 ati Oṣu Kini ọdun 2014.

Kọ ifiranṣẹ rẹ nibi ki o si fi si wa